298 related articles for article (PubMed ID: 6332851)
21. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
Rocklin RE; Thistle L; Audera C
J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
[TBL] [Abstract][Full Text] [Related]
22. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
23. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
Koster FT; Williams JC; Goodwin JS
J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
[TBL] [Abstract][Full Text] [Related]
24. Sequential effects of prostaglandins and interferon-gamma on differentiation of CD8+ suppressor cells.
ElMasry MN; Fox EJ; Rich RR
J Immunol; 1987 Aug; 139(3):688-94. PubMed ID: 2955048
[TBL] [Abstract][Full Text] [Related]
25. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor.
Goldstein H; Volkman DJ; Ambrus JL; Fauci AS
J Immunol; 1985 Jul; 135(1):339-43. PubMed ID: 3923106
[TBL] [Abstract][Full Text] [Related]
27. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
Walker C; Kristensen F; Bettens F; deWeck AL
J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
[TBL] [Abstract][Full Text] [Related]
28. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2-induced inhibition of the in vitro immune response by SRBC-stimulated human lymphocytes.
Misefari A; Valenti A; Cavallaro A; Sofo V; Santarpia G; Salmeri FM; Venza Teti D
Immunopharmacol Immunotoxicol; 1991; 13(1-2):169-81. PubMed ID: 1770218
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
31. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen.
Garrone P; Galibert L; Rousset F; Fu SM; Banchereau J
J Immunol; 1994 May; 152(9):4282-90. PubMed ID: 7512590
[TBL] [Abstract][Full Text] [Related]
32. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
[TBL] [Abstract][Full Text] [Related]
33. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E.
Hasler F; Bluestein HG; Zvaifler NJ; Epstein LB
J Immunol; 1983 Aug; 131(2):768-72. PubMed ID: 6306107
[TBL] [Abstract][Full Text] [Related]
35. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
Butler JL; Ambrus JL; Fauci AS
J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
[TBL] [Abstract][Full Text] [Related]
36. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
Brown SL; Van Epps DE
J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
[TBL] [Abstract][Full Text] [Related]
37. Effect of prostaglandin E2 on pokeweed mitogen-activated human lymphocyte cultures.
Teti DV; Cavallaro A; Valenti A; Santarpia G; Sofo V; Misefari A
Immunopharmacol Immunotoxicol; 1989; 11(4):687-700. PubMed ID: 2516862
[TBL] [Abstract][Full Text] [Related]
38. Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes.
Taylor DS; Nowell PC; Kornbluth J
J Immunol; 1987 Sep; 139(6):1792-6. PubMed ID: 3497978
[TBL] [Abstract][Full Text] [Related]
39. Production of B cell growth factor by normal human B cells.
Jurgensen CH; Ambrus JL; Fauci AS
J Immunol; 1986 Jun; 136(12):4542-7. PubMed ID: 3519772
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
